Pharmaceutical Technology-10-02-2013

Pharmaceutical Technology

Unraveling the Mystery of Ireland's Pharm-Attractions

October 02, 2013

Industry Insider

37

10

Ireland?s life-sciences sector has grown significantly since the 1960s. To gain insights into the competitive edge that Ireland offers to the pharmaceutical industry, Pharmaceutical Technology Europe spoke with Barry Heavey from IDA Ireland, which is a government agency responsible for attracting pharmaceutical and biotech companies to Ireland.

Ensuring Compliance with Drug Accountability Requirements

October 02, 2013

Ask the Expert

37

10

Kurt Lumsden, Director Client Services at Perceptive Informatics, a subsidiary of PAREXEL, discusses regulatory requirements for the drug accountability process.

Tracking Quality in Drug Manufacturing

October 02, 2013

Regulation & Compliance

37

10

Recent FDA enforcement activity reveals issues with vial-filling, adequacy of QA/QC procedures, particulate matter in inhalation powders and injectables, and drug labeling.

Ruggedness of Visible Residue Limits for Cleaning-Part III: Visible Residue Limits for Different Materials of Construction

October 02, 2013

Peer Reviewed

37

10

The authors evaluated a variety of materials of construction (MOCs) and found that visible residue limits (VRLs) were higher on some MOCs than on stainless steel. The optimal viewing conditions were dependent on the MOC and the viewing background. The risk of a cleaning failure due to visual failure for different MOCs can be mitigated or eliminated using complementary cleaning validation studies.

Helium Integrity Testing of Single-Use Vessels

October 02, 2013

Troubleshooting

37

10

The rapid uptake of single-use vessels for use in bioprocessing applications has made assuring integrity that much more crucial; helium integrity testing can be used to test integrity and prevent failures.

Changing the Dynamic of CROs

October 02, 2013

Guest Editorial

37

10

Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.

Elucidating Biosimilars Characterization

October 02, 2013

BioForum

37

10

Industry experts discuss the importance of characterization studies during biosimilars development and related analytical methods.

Evaluating Strategies for Oral Absorption Enhancement

October 02, 2013

Special Report: Drug Delivery

37

10

Scientists from the CDMO Metrics talk about the challenges in developing oral formulations for poorly permeable drugs and the strategies used to enhance oral absorption in the gastrointestinal tract.

Overcoming Challenges in Fluorine-Based Chemistry

October 02, 2013

API Synthesis & Manufacturing

37

10

Fluorinated molecules play an important role as pharmaceutical compounds. Recent advances seek to overcome the challenges of selective and late-stage insertion of fluorine into small molecules.

Pharmaceutical Technology, October 2013 Issue (PDF)

October 02, 2013

Issue PDF

37

10

Click the title above to open the Pharmaceutical Technology October 2013 issue in an interactive PDF format.